14.05
price down icon2.43%   -0.35
after-market  After Hours:  13.98  -0.07   -0.50%
loading

Novavax, Inc. Stock (NVAX) Forecast

The Novavax, Inc. (NVAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.203, representing a -77.20% decrease from the current price of $14.05. The highest analyst price target is $4.1744, and the lowest is $2.2316.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 22.98 (+63.57% Upside)
loading

Is Novavax, Inc. (NVAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 49.39 Neutral
STOCH(9,6) 13.00 Buy
STOCHRSI(14) 8.0172 Buy
MACD(12,26) 1.4061 Sell
ADX(14) 43.70 Buy
William %R -94.69 Buy
CCI(14) -97.66 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
16.85
Sell
15.73
Sell
MA20
16.19
Sell
15.08
Sell
MA50
10.05
Buy
11.75
Buy
MA100
7.3501
Buy
9.1819
Buy
MA200
6.7893
Buy
7.8501
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, NVAX could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on NVAX, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 49.39 indicates that NVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 13 indicates that NVAX is oversold. This indicates that NVAX price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.0172 indicates that NVAX is oversold. This suggests that NVAX price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 43.7 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.66 indicates that NVAX is still oversold but not to an extreme extent.

Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Novavax, Inc. financial reports and earnings history, Novavax, Inc. (NVAX) stock could reach $4.1836 by 2030, $5.3488 by 2040 and $83.18 by 2050. See the projected annual prices until 2050 of the Novavax, Inc. stock below:

  • Novavax, Inc. (NVAX) is expected to reach an average price of $2.8087 in 2035, with a high prediction of $4.7215 and a low estimate of $2.5387. This indicates an $-80.01% rise from the last recorded price of $14.05.
  • Novavax, Inc. (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3442, representing an $-76.20% surge from its current level. The forecast ranges from a conservative $2.508 to a sky-high $5.3488.
  • Our analysts predict Novavax, Inc. (NVAX) to jump -26.73% by 2045, soaring from $10.22 to an average price of $10.29, potentially reaching $27.34. While $10.22 is the low estimate, the potential upside is significant.
  • Novavax, Inc. (NVAX) stock is expected to climb by 2050, reaching an average of $74.50, a $430.22% jump from its current level. However, a wide range of estimates exists, with high and low targets of $83.18 and $58.01, respectively, highlighting the market's uncertainty.

Novavax, Inc. Stock (NVAX) Year by Year Forecast

Novavax, Inc. Stock (NVAX) Price Forecast for 2024

Our forecast for NVAX stock price in 2024 now indicates an average price target of $4.7379 with a high forecast of $7.74 and a low forecast of $1.7359. The average prediction reflects an decrease of -66.28% from the last recorded price of $14.05.
Month Average Low High Change from today's price
July, 2024 $2.5016 $2.2316 $4.1744 -82.19%
August, 2024 $4.3788 $2.1918 $6.3188 -68.83%
September, 2024 $4.726 $3.4024 $5.826 -66.36%
October, 2024 $2.6851 $2.5651 $4.8078 -80.89%
November, 2024 $2.8023 $2.2887 $3.0423 -80.06%
December, 2024 $2.5545 $1.7359 $3.8395 -81.82%

Novavax, Inc. Stock (NVAX) Price Forecast for 2025

Novavax, Inc. Stock (NVAX) is expected to reach an average price of $94.77 in 2025, with a high prediction of $187.67 and a low estimate of $1.8639. This indicates an +574.50% rise from the last recorded price of $14.05.
Month Average Low High Change from today's price
January, 2025 $2.6235 $2.0531 $2.8085 -81.33%
February, 2025 $5.7257 $1.8639 $8.1539 -59.25%
March, 2025 $13.86 $4.7675 $15.92 -1.37%
April, 2025 $11.57 $4.9983 $13.16 -17.64%
May, 2025 $22.03 $11.45 $24.57 +56.78%
June, 2025 $41.88 $14.65 $44.23 +198.05%
July, 2025 $63.17 $38.75 $64.32 +349.58%
August, 2025 $92.62 $57.56 $110.03 +559.24%
September, 2025 $168.56 $93.52 $187.67 +1,100%
October, 2025 $91.21 $84.94 $179.97 +549.17%
November, 2025 $106.64 $81.50 $124.82 +658.97%
December, 2025 $79.00 $76.79 $120.21 +462.31%

Novavax, Inc. Stock (NVAX) Price Forecast for 2026

The predicted value for Novavax, Inc. (NVAX) in 2026 is set at an average of $202.45. Estimates vary from a peak of $330.00 to a trough of $74.89, indicating an +1,341% surge from the present price of $14.05.
Month Average Low High Change from today's price
January, 2026 $123.99 $74.89 $130.30 +782.51%
February, 2026 $123.11 $104.42 $148.81 +776.22%
March, 2026 $125.75 $105.39 $135.89 +794.99%
April, 2026 $276.21 $119.58 $330.00 +1,866%
May, 2026 $226.58 $145.72 $275.48 +1,513%
June, 2026 $178.08 $157.42 $239.81 +1,167%
July, 2026 $130.04 $115.47 $262.02 +825.54%
August, 2026 $208.04 $126.93 $212.86 +1,381%
September, 2026 $186.96 $167.16 $227.86 +1,231%
October, 2026 $188.25 $170.38 $245.02 +1,240%
November, 2026 $236.92 $190.37 $258.37 +1,586%
December, 2026 $205.44 $196.39 $276.18 +1,362%

Novavax, Inc. Stock (NVAX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Novavax, Inc. (NVAX) is $134.13, with a high forecast of $234.91 and a low forecast of $33.35. This indicates an +854.66% increase from the last price of $14.05.
Month Average Low High Change from today's price
January, 2027 $132.98 $119.75 $190.79 +846.45%
February, 2027 $190.74 $128.48 $199.88 +1,258%
March, 2027 $215.73 $136.66 $227.41 +1,435%
April, 2027 $109.24 $99.52 $234.91 +677.50%
May, 2027 $87.76 $64.80 $105.95 +524.60%
June, 2027 $70.16 $67.93 $99.82 +399.33%
July, 2027 $72.09 $64.26 $84.04 +413.12%
August, 2027 $45.10 $44.48 $76.10 +221.00%
September, 2027 $53.75 $39.79 $61.68 +282.55%
October, 2027 $38.71 $33.35 $55.95 +175.49%
November, 2027 $74.59 $37.85 $75.24 +430.91%
December, 2027 $39.95 $36.64 $73.81 +184.36%

Novavax, Inc. Stock (NVAX) Price Forecast for 2028

In 2028, Novavax, Inc. (NVAX) is projected to reach an average price of $23.33, with a high projection of $42.50 and a low estimate of $4.1541. This indicates an +66.04% rise from the last price of $14.05.
Month Average Low High Change from today's price
January, 2028 $28.88 $28.81 $42.50 +105.55%
February, 2028 $16.70 $16.35 $31.86 +18.84%
March, 2028 $20.78 $14.50 $23.15 +47.87%
April, 2028 $15.05 $14.83 $24.17 +7.14%
May, 2028 $8.182 $7.8802 $17.07 -41.76%
June, 2028 $10.08 $7.2738 $12.23 -28.26%
July, 2028 $8.4164 $8.0164 $11.18 -40.10%
August, 2028 $5.0655 $4.7955 $8.8183 -63.95%
September, 2028 $7.0127 $4.1541 $7.5027 -50.09%
October, 2028 $6.2699 $5.4499 $8.2363 -55.37%
November, 2028 $6.1889 $5.2053 $9.9217 -55.95%
December, 2028 $6.0061 $5.1361 $7.0975 -57.25%

Novavax, Inc. Stock (NVAX) Price Forecast for 2029

The 2029 price forecast for Novavax, Inc. Stock (NVAX) is $5.5239 on average, with a high prediction of $8.8977 and a low estimate of $2.15. This represents an -60.68% decrease from the previous price of $14.05.
Month Average Low High Change from today's price
January, 2029 $7.8651 $5.4779 $8.7597 -44.02%
February, 2029 $6.6423 $5.4337 $8.1923 -52.72%
March, 2029 $6.3095 $5.8995 $8.8977 -55.09%
April, 2029 $5.6567 $5.3253 $6.7549 -59.74%
May, 2029 $4.8557 $4.5657 $6.1057 -65.44%
June, 2029 $4.1929 $3.9193 $5.1275 -70.16%
July, 2029 $3.4302 $3.4302 $4.6747 -75.59%
August, 2029 $2.6392 $2.5892 $3.972 -81.22%
September, 2029 $3.9364 $2.1752 $4.1064 -71.98%
October, 2029 $3.3554 $2.8782 $4.6982 -76.12%
November, 2029 $2.6326 $2.4726 $3.6072 -81.26%
December, 2029 $2.81 $2.15 $5.88 -80.00%

Novavax, Inc. Stock (NVAX) Price Forecast for 2030

Novavax, Inc. Stock (NVAX) is expected to reach an average price of $7.107 in 2030, with a high forecast of $14.15 and a low forecast of $0.0683. This signifies an -49.42% decrease from the last price of $14.05.
Month Average Low High Change from today's price
January, 2030 $1.313 $0.9481 $4.1836 -90.65%
February, 2030 $1.3024 $1.1524 $3.4552 -90.73%
March, 2030 $0.6559 $0.3932 $1.216 -95.33%
April, 2030 $2.2613 $0.3589 $4.4877 -83.91%
May, 2030 $1.4393 $1.3593 $4.0021 -89.76%
June, 2030 $0.8237 $0.5437 $1.5129 -94.14%
July, 2030 $0.1317 $0.0683 $1.2345 -99.06%
August, 2030 $0.4242 $0.0953 $2.0389 -96.98%
September, 2030 $0.3556 $0.2777 $1.1406 -97.47%
October, 2030 $4.0786 $0.076 $6.3678 -70.97%
November, 2030 $4.753 $3.7622 $14.15 -66.17%
December, 2030 $11.80 $3.2266 $12.03 -16.03%
$85.02
price up icon 1.81%
$25.78
price down icon 1.57%
$159.38
price down icon 1.97%
$157.30
price down icon 1.93%
$88.44
price down icon 3.95%
$378.30
price down icon 2.25%
Cap:     |  Volume (24h):